Il s'agit d'un essai multicentrique à plusieurs bras évaluant l'activité antitumorale, la sécurité et l'infiltration immunitaire de IO102-IO103 en association avec le pembrolizumab comme traitement néoadjuvant et adjuvant.

Dans notre centre, à Gustave Roussy, cet essai inclura des patients atteints de mélanomes résécables.

Pendant la période de traitement néoadjuvant, les patients recevront IO102-IO103 (injection par voie sous-cutanée) et pembrolizumab toutes les 3 semaines pendant 3 cycles (mélanome).

Read more about CSET 3737

01/29/2024

The FOSTER-CabOs project has received funding for a clinical trial concerning osteosarcoma

The ARC Foundation, which has joined forces with four European cancer charities under the ATTRACT grant, awards funding to the FOSTER-CabOS project. The grant obtained through this call for projects will fund a European Phase III clinical trial to evaluate cabozantinib, a tyrosine kinase inhibitor, to treat osteosarcoma, a rare type cancer.

Dossier de presse - La recherche à Gustave Roussy

back to job offer list

back to clinical trials

Dossier de presse - 23 janvier 2024

La recherche à Gustave Roussy
Changements de paradigmes

En perspective de la journée mondiale de lutte contre le cancer qui aura lieu le 4 février, Gustave Roussy a organisé une conférence de presse le 23 janvier 2024.

Press releases 2024

back to job offer list

back to clinical trials

2024 Press releases

Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow®, innovative solution dedicated to oncology imaging
Press release, 3 december 2024

The Department of Therapeutic innovation and early stage trials strengthened by the appointment of professor Chirstophe Massard as its head

back to job offer list

back to clinical trials

Villejuif, 17th January 2024

Chromatin function in DNA repair - lab members

back to job offer list

back to clinical trials

Chromatin function in DNA repair

Contacts

Beatrice Rondinelli
ATIP/Avenir team “Chromatin function in DNA repair"
Genome Integrity & Cancers
UMR9019 – CNRS Paris-Saclay
GUSTAVE ROUSSY - PR2, Room 401
114, rue Edouard Vaillant
94805 - Villejuif Cedex
FRANCE
Email : beatrice.rondinelli@gustaveroussy.fr